• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病合并心力衰竭患者的长期 LVEF 轨迹:糖尿病心肌病可能是功能下降的基础。

Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline.

机构信息

Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.

Endocrinology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.

出版信息

Cardiovasc Diabetol. 2020 Mar 23;19(1):38. doi: 10.1186/s12933-020-01011-w.

DOI:10.1186/s12933-020-01011-w
PMID:32293458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7092450/
Abstract

BACKGROUND

Left ventricular ejection fraction (LVEF) trajectories and functional recovery with current heart failure (HF) management is increasingly recognized. Type 2 diabetes mellitus (T2D) leads to a worse prognosis in HF patients. However, it is unknown whether T2D interferes with LVEF trajectories. The aim of this study was to prospectively assess very long-term (up to 15 years) LVEF trajectories in patients with and without T2D and underlying HF.

METHODS

Ambulatory patients admitted to a multidisciplinary HF clinic were prospectively evaluated by scheduled two-dimensional echocardiography at baseline, 1 year, and then every 2 years afterwards, up to 15 years. Statistical analyses of LVEF change with time were performed using the linear mixed effects (LME) models, and locally weighted error sum of squares (Loess) curves were plotted.

RESULTS

Of the 1921 patients, 461 diabetic and 699 non-diabetic patients with LVEF < 50% were included in the study. The mean number of echocardiography measurements performed in diabetic patients was 3.3 ± 1.6. Early LVEF recovery was similar in diabetic and non-diabetic patients, but Loess curves showed a more pronounced inverted U shape in diabetics with a more pronounced decline after 9 years. LME analysis showed a statistical interaction between T2D and LVEF trajectory over time (p = 0.009), which was statistically significant in patients with ischemic etiologies (p < 0.001). Other variables that showed an interaction between LVEF trajectories and T2D were male sex (p = 0.04) and HF duration (p = 0.008).

CONCLUSIONS

LVEF trajectories in T2D patients with depressed systolic function showed a pronounced inverted U shape with a marked decline after 9 years. Diabetic cardiomyopathy may underlie the functional decline observed.

摘要

背景

左心室射血分数(LVEF)轨迹和心力衰竭(HF)管理的功能恢复越来越受到重视。2 型糖尿病(T2D)导致 HF 患者预后更差。然而,尚不清楚 T2D 是否会干扰 LVEF 轨迹。本研究旨在前瞻性评估 T2D 合并和不合并 HF 的患者的 LVEF 非常长期(长达 15 年)轨迹。

方法

多学科 HF 诊所的门诊患者通过二维超声心动图在基线、1 年和之后每 2 年进行前瞻性评估,最长可达 15 年。使用线性混合效应(LME)模型对 LVEF 随时间的变化进行统计分析,并绘制局部加权误差和平方(Loess)曲线。

结果

在 1921 例患者中,纳入了 461 例糖尿病和 699 例 LVEF<50%的非糖尿病患者。糖尿病患者的平均超声心动图测量次数为 3.3±1.6 次。糖尿病患者和非糖尿病患者的早期 LVEF 恢复相似,但 Loess 曲线显示糖尿病患者的倒 U 形更为明显,9 年后下降更为明显。LME 分析显示 T2D 和 LVEF 轨迹之间存在统计学上的时间交互作用(p=0.009),在缺血性病因患者中具有统计学意义(p<0.001)。其他显示 LVEF 轨迹与 T2D 之间存在交互作用的变量包括男性(p=0.04)和 HF 持续时间(p=0.008)。

结论

收缩功能障碍的 T2D 患者的 LVEF 轨迹呈明显的倒 U 形,9 年后明显下降。观察到的功能下降可能是糖尿病心肌病的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4010/7092450/11fe1a42a1d4/12933_2020_1011_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4010/7092450/cee3152a3fa1/12933_2020_1011_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4010/7092450/598deddf7683/12933_2020_1011_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4010/7092450/11fe1a42a1d4/12933_2020_1011_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4010/7092450/cee3152a3fa1/12933_2020_1011_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4010/7092450/598deddf7683/12933_2020_1011_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4010/7092450/11fe1a42a1d4/12933_2020_1011_Fig3_HTML.jpg

相似文献

1
Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline.2 型糖尿病合并心力衰竭患者的长期 LVEF 轨迹:糖尿病心肌病可能是功能下降的基础。
Cardiovasc Diabetol. 2020 Mar 23;19(1):38. doi: 10.1186/s12933-020-01011-w.
2
Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy.糖尿病对非缺血性扩张型心肌病患者左心室纵向功能的影响。
Cardiovasc Diabetol. 2020 Jun 13;19(1):84. doi: 10.1186/s12933-020-01063-y.
3
Dynamic Trajectories of Left Ventricular Ejection Fraction in Heart Failure.心力衰竭患者左心室射血分数的动态轨迹。
J Am Coll Cardiol. 2018 Aug 7;72(6):591-601. doi: 10.1016/j.jacc.2018.05.042.
4
Diabetes mellitus is associated with adverse structural and functional cardiac remodelling in chronic heart failure with reduced ejection fraction.糖尿病与射血分数降低的慢性心力衰竭中不良的心脏结构和功能重塑有关。
Diab Vasc Dis Res. 2016 Sep;13(5):331-40. doi: 10.1177/1479164116653342. Epub 2016 Jun 22.
5
Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus.糖化波动与 2 型糖尿病患者左心室舒张功能的关系。
Cardiovasc Diabetol. 2019 Dec 5;18(1):166. doi: 10.1186/s12933-019-0971-5.
6
Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure.2 型糖尿病中非缺血性心力衰竭 B 期的诊断:心力衰竭预测的最佳参数。
JACC Cardiovasc Imaging. 2018 Oct;11(10):1390-1400. doi: 10.1016/j.jcmg.2018.03.015. Epub 2018 May 16.
7
Effects of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus in Open-Label, Marker-Stratified Randomized, Parallel-Group Comparison, Standard Treatment-Controlled Multicenter Trial (TOPLEVEL Study): Rationale and Study Design.在开放标签、标志物分层随机、平行分组比较、标准治疗对照多中心试验(TOPLEVEL 研究)中,替格列汀对 2 型糖尿病患者进行左心室舒张功能障碍的进展的影响:原理和研究设计。
Cardiovasc Drugs Ther. 2019 Jun;33(3):363-370. doi: 10.1007/s10557-019-06871-3.
8
Longitudinal Changes in Cardiac Structure and Function From Adolescence to Young Adulthood in Participants With Type 2 Diabetes Mellitus: The TODAY Follow-Up Study.2 型糖尿病患者从青少年到青年期的心脏结构和功能的纵向变化: TODAY 随访研究。
Circ Heart Fail. 2020 Jun;13(6):e006685. doi: 10.1161/CIRCHEARTFAILURE.119.006685. Epub 2020 Jun 5.
9
Left ventricular systolic function deterioration during dobutamine stress echocardiography as an early manifestation of diabetic cardiomyopathy and reversal by optimized therapeutic approach.多巴酚丁胺负荷超声心动图检查中左心室收缩功能恶化可作为糖尿病心肌病的早期表现,并可通过优化治疗方法逆转。
Int J Cardiovasc Imaging. 2012 Aug;28(6):1329-39. doi: 10.1007/s10554-011-9938-7. Epub 2011 Aug 18.
10
Evaluation of the role of left atrial strain using two-dimensional speckle tracking echocardiography in patients with diabetes mellitus and heart failure with preserved left ventricular ejection fraction.二维斑点追踪超声心动图评估左心房应变在糖尿病合并左心室射血分数保留的心力衰竭患者中的作用
Diab Vasc Dis Res. 2016 Nov;13(6):384-394. doi: 10.1177/1479164116655558. Epub 2016 Jul 12.

引用本文的文献

1
Effects of insulin-induced hypoglycaemia on cardiac function in people with type 1 and type 2 diabetes and people without diabetes.胰岛素诱导的低血糖对1型和2型糖尿病患者以及非糖尿病患者心脏功能的影响。
Diabetes Obes Metab. 2025 May;27(5):2768-2776. doi: 10.1111/dom.16283. Epub 2025 Mar 5.
2
Long-term trajectory of estimated glomerular filtration rate in ambulatory patients with type 2 diabetes and heart failure: clinical insights and prognostic implications.2型糖尿病合并心力衰竭门诊患者估算肾小球滤过率的长期轨迹:临床见解与预后意义
Cardiovasc Diabetol. 2025 Mar 5;24(1):104. doi: 10.1186/s12933-025-02632-9.
3

本文引用的文献

1
Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes.解析恩格列净在射血分数降低的心力衰竭(无论有无糖尿病)中的分子作用机制
JACC Basic Transl Sci. 2019 Oct 23;4(7):831-840. doi: 10.1016/j.jacbts.2019.07.010. eCollection 2019 Nov.
2
Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension.长期服用二甲双胍与 2 型糖尿病合并高血压患者射血分数保留心力衰竭进展的关系。
Int J Cardiol. 2020 May 1;306:140-145. doi: 10.1016/j.ijcard.2019.11.087. Epub 2019 Nov 7.
3
Preclinical evidence and possible mechanisms of cardioprotective effects of resveratrol in diabetic cardiomyopathy: a systematic review and meta-analysis.
白藜芦醇对糖尿病性心肌病心脏保护作用的临床前证据及可能机制:一项系统评价和荟萃分析
Diabetol Metab Syndr. 2024 Nov 17;16(1):275. doi: 10.1186/s13098-024-01512-8.
4
The double burden: type 1 diabetes and heart failure-a comprehensive review.双重负担:1 型糖尿病与心力衰竭——全面综述。
Cardiovasc Diabetol. 2024 Feb 12;23(1):65. doi: 10.1186/s12933-024-02136-y.
5
The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention.美国心脏协会/美国心脏病学会/美国心力衰竭学会2022年心力衰竭指南:将重点转向心力衰竭预防。
Am J Prev Cardiol. 2023 Jul 30;15:100527. doi: 10.1016/j.ajpc.2023.100527. eCollection 2023 Sep.
6
Combined treatment with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure with reduced ejection fraction.沙库巴曲缬沙坦与达格列净联合治疗射血分数降低的心力衰竭患者。
Front Cardiovasc Med. 2023 Mar 22;10:1097066. doi: 10.3389/fcvm.2023.1097066. eCollection 2023.
7
Diabetic cardiomyopathy: Clinical phenotype and practice.糖尿病心肌病:临床表型与实践。
Front Endocrinol (Lausanne). 2022 Dec 7;13:1032268. doi: 10.3389/fendo.2022.1032268. eCollection 2022.
8
Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association.心力衰竭:糖尿病被低估的并发症。美国糖尿病协会共识报告。
Diabetes Care. 2022 Jul 7;45(7):1670-1690. doi: 10.2337/dci22-0014.
9
Nurse-led care versus usual care on cardiovascular risk factors for patients with type 2 diabetes: a systematic review and meta-analysis.护士主导的护理与常规护理对 2 型糖尿病患者心血管风险因素的影响:系统评价和荟萃分析。
BMJ Open. 2022 Mar 28;12(3):e058533. doi: 10.1136/bmjopen-2021-058533.
10
Effect of diabetes mellitus on the development of left ventricular contractile dysfunction in women with heart failure and preserved ejection fraction.糖尿病对射血分数保留的心力衰竭女性左心室收缩功能障碍发展的影响。
Cardiovasc Diabetol. 2021 Sep 14;20(1):185. doi: 10.1186/s12933-021-01379-3.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
达格列净治疗射血分数降低的心力衰竭患者。
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.
4
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction.沙库巴曲缬沙坦治疗起始后N末端前B型利钠肽的变化与射血分数降低的心力衰竭患者心脏结构和功能的关联
JAMA. 2019 Sep 17;322(11):1085-1095. doi: 10.1001/jama.2019.12821.
5
Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction.达格列净可改善射血分数保留型心力衰竭猪模型的左心室重构和主动脉交感神经张力。
Cardiovasc Diabetol. 2019 Aug 20;18(1):107. doi: 10.1186/s12933-019-0914-1.
6
Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study.心力衰竭与新发糖尿病的预后影响和发生率:一项全国性队列研究。
Cardiovasc Diabetol. 2019 Jun 12;18(1):79. doi: 10.1186/s12933-019-0883-4.
7
Left ventricular concentric geometry predicts incident diabetes mellitus independent of established risk factors in the general population: the Copenhagen City Heart Study.左心室向心性重构独立于一般人群中已确立的危险因素预测 2 型糖尿病的发生:哥本哈根城市心脏研究。
Cardiovasc Diabetol. 2019 Mar 20;18(1):37. doi: 10.1186/s12933-019-0842-0.
8
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.达格列净与 2 型糖尿病患者的心血管结局
N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10.
9
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.SGLT2 抑制剂与心血管获益的机制:最新综述。
Diabetologia. 2018 Oct;61(10):2108-2117. doi: 10.1007/s00125-018-4670-7. Epub 2018 Aug 22.
10
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.2 型糖尿病患者的风险因素、死亡率和心血管结局。
N Engl J Med. 2018 Aug 16;379(7):633-644. doi: 10.1056/NEJMoa1800256.